First Washington Corp’s Pfizer PFE Stock Holding History

First Washington Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,000	Closed	-$204K	–	59
2023 Q1	$204K	Hold	5,000	–	–	0.1%	55
2022 Q4	$256K	Sell	5,000 -57,217	-92%	-$2.74M	0.13%	55
2022 Q3	$2.72M	Hold	62,217	–	–	1.37%	37
2022 Q2	$3.26M	Hold	62,217	–	–	1.51%	35
2022 Q1	$3.22M	Buy	62,217 +57,217	+1,144%	+$2.97M	1.3%	38
2021 Q4	$295K	Hold	5,000	–	–	0.11%	61
2021 Q3	$215K	Hold	5,000	–	–	0.08%	65
2021 Q2	$196K	Sell	5,000 -118,000	-96%	-$4.59M	0.07%	63
2021 Q1	$4.46M	Buy	123,000 +118,000	+2,360%	+$4.19M	1.76%	20
2020 Q4	$184K	Sell	5,000 -270	-5%	-$9.9K	0.08%	56
2020 Q3	$184K	Hold	5,270	–	–	0.11%	55
2020 Q2	$164K	Sell	5,270 -28,985	-85%	-$985K	0.1%	56
2020 Q1	$1.06M	Buy	34,255 +28,985	+550%	+$988K	0.67%	46
2019 Q4	$196K	Sell	5,270 -422	-7%	-$15K	0.09%	48
2019 Q3	$194K	Hold	5,692	–	–	0.1%	46
2019 Q2	$234K	Hold	5,692	–	–	0.12%	47
2019 Q1	$229K	Hold	5,692	–	–	0.12%	49
2018 Q4	$236K	Hold	5,692	–	–	0.13%	49
2018 Q3	$238K	Buy	5,692 +422	+8%	+$16.2K	0.11%	50
2018 Q2	$181K	Hold	5,270	–	–	0.09%	48
2018 Q1	$177K	Hold	5,270	–	–	0.09%	48
2017 Q4	$181K	Hold	5,270	–	–	0.09%	51
2017 Q3	$179K	Hold	5,270	–	–	0.09%	49
2017 Q2	$1.68K	Hold	5,270	–	–	0.08%	52
2017 Q1	$171K	Hold	5,270	–	–	0.09%	50
2016 Q4	$162K	Hold	5,270	–	–	0.09%	51
2016 Q3	$169K	Hold	5,270	–	–	0.09%	50
2016 Q2	$176K	Hold	5,270	–	–	0.1%	54
2016 Q1	$148K	Hold	5,270	–	–	0.09%	54
2015 Q4	$161K	Hold	5,270	–	–	0.09%	54
2015 Q3	$157K	Hold	5,270	–	–	0.09%	60
2015 Q2	$168K	Hold	5,270	–	–	0.09%	60
2015 Q1	$174K	Hold	5,270	–	–	0.1%	57
2014 Q4	$156K	Hold	5,270	–	–	0.09%	59
2014 Q3	$148K	Hold	5,270	–	–	0.08%	61
2014 Q2	$148K	Hold	5,270	–	–	0.08%	69
2014 Q1	$161K	Hold	5,270	–	–	0.09%	68
2013 Q4	$153K	Hold	5,270	–	–	0.08%	70
2013 Q3	$144K	Hold	5,270	–	–	0.11%	67
2013 Q2	$140K	Buy	+5,270	New	+$146K	0.11%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Washington Corp's PFE Position: Q2 2023 in Review

First Washington Corp sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,000 shares — an estimated $204K sold.

First Washington Corp first reported a position in PFE in Q2 2013 and held it in 40 quarters. The position peaked at $4.46M in Q1 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

First Washington Corp reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
First Washington Corp sold 5,000 Pfizer shares in Q2 2023, an estimated $204K.
First Washington Corp first reported a position in Pfizer in Q2 2013 and held it in 40 quarters.
First Washington Corp's Pfizer position peaked at $4.46M in Q1 2021.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on First Washington Corp's 13F filing for Q2 2023, filed 11 Aug 2023.